The MLH1 variant is correlated with the highest risk of developing CRC [21, 22], with a cumulative cancer incidence ranging from 0% (age 30) to 48.3% (age 75) in females and from 4.5% (age 30) to 57.1% (age 75) in males [20]. This evidence concerns the gene MLH1 and colorectal carcinoma.